CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
RESPOND is a platform that simplifies the identification of immune clonotypes for targeted vaccine and therapeutic development. By integrating various algorithmic methods, it provides users with tailored solutions to enhance drug discovery efficiency in personalized medicine and other applications.
Personalized medicine promises to exploit the diversity of human immune repertoires to design targeted T cell and B cell--based vaccines and therapeutics.
However, even for mass vaccine design, identifying responding clonotypes to new viruses is costly, labor intensive and time consuming.RESPOND turns existing algorithmic solutions for identifying responding immune clonotypes into a user-friendly platform to aid drug and therapeutics discovery. RESPOND combines different algorithmic solutions an…
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
